President Donald Trump signs an executive order for new tariffs at the Rose Garden, April 2, 2025 (Andrew Leyden/NurPhoto via AP Images)

April 2, 2025 08:08 PM EDTUpdated 06:24 PM

Manufacturing

Chaotic tariff rollout leaves as many questions as answers for drugmakers

Max Bayer

Pharma Reporter

A rapid cascade of seemingly conflicting details from President Donald Trump’s tariff announcement left large drugmakers on Wednesday trying to figure out …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Chaotic tariff rollout leaves as many questions as answers for drugmakers

Max Bayer

Pharma Reporter

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

Caribou lays off 32% of staff, cuts lupus cell therapy program before first patient

Merck KGaA closes in on SpringWorks deal at $3.5B price point

Paul Stoffels on retiring from Galapagos; Boehringer Ingelheim switches up leadership

AbbVie's immunology franchise remains a powerhouse, as Skyrizi, Rinvoq combine for $5B

Versant's latest biotech focuses on inflammatory diseases

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Chaot­ic tar­iff roll­out leaves as many ques­tions as an­swers for drug­mak­ers

Pharma Reporter

Sign up to read this article for free.

Celldex Therapeutics

Hampton, NJ, USA

Chaotic tariff rollout leaves as many questions as answers for drugmakers